文献速递类风湿关节炎其他结缔组织病

工程化IgG靶标鉴定临床与病理生理相关的类风湿因子表位

Identification of Clinically and Pathophysiologically Relevant Rheumatoid Factor Epitopes by Engineered IgG Targets.
PubMed 文献 · Arthritis Rheumatol · 2020-10-25

本研究利用生物工程化、天然折叠的IgG-Fc靶标分析血清中类风湿因子(RF)的表位结合模式,对象包括血清阳性关节痛、类风湿关节炎(RA)和原发性干燥综合征(SS)患者。RF主要结合Fc肘部区域,少数结合尾部区域,而Fc受体结合区几乎不被靶向。针对IgG-Fc尾部区域的限制性反应与抗瓜氨酸化蛋白抗体(ACPA)阳性率较低及关节痛患者关节炎发展较少相关,而尾部与肘部联合反应与更多关节炎发展相关;尾部区域反应在RA中远多于原发性SS。

要点

  • RF主要结合IgG-Fc肘部区域,尾部区域结合较少,受体结合区几乎不靶向。
  • 仅尾部区域反应与关节痛患者ACPA阳性率低及关节炎发展少相关。
  • 尾部与肘部联合反应与关节痛患者更多关节炎发展相关。

核心结论

  • 生物工程化IgG靶标可表征RF反应模式,揭示与ACPA检测及关节痛患者关节炎发展相关的模式,并能区分RA与原发性SS。

研究设计与样本

  • 研究分析血清阳性关节痛、RA和原发性SS患者血清中RF反应模式,使用生物工程化、天然折叠的IgG-Fc靶标选择性检测RF对IgG-Fc不同区域的结合。

主要发现

  • RF反应主要结合Fc肘部区域,少数结合Fc尾部区域,Fc受体结合区几乎不被靶向。
  • 针对IgG-Fc尾部区域的限制性反应与关节痛患者ACPA阳性较少及关节炎发展较少相关。
  • 针对IgG-Fc尾部与肘部区域的联合反应与关节痛患者更多关节炎发展相关。
  • 针对IgG-Fc尾部区域的反应在RA中远多于原发性SS。

临床怎么用

  • 该新方法可提升RF的临床价值,通过RF表位反应模式辅助评估关节痛患者的关节炎发展风险及鉴别RA与原发性SS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid factors (RFs), which are anti-IgG autoantibodies strongly associated with rheumatoid arthritis (RA), are also found in other diseases and in healthy individuals. RFs bind to various epitopes in the constant (Fc-) domain of IgG. Therefore, disease-specific reactivity patterns may exist. This study was undertaken in order to develop a new approach to dissecting RF epitope binding patterns across different diseases. METHODS: We analyzed RF reactivity patterns in serum from patients with seropositive arthralgia, patients with RA, and patients with primary Sjögren's syndrome (SS) using bioengineered, natively folded IgG-Fc targets that demonstrated selective RF binding toward several distinct regions of the IgG-Fc domain. RESULTS: Rheumatoid factor responses primarily bound the Fc Elbow region, with a smaller number of RFs binding the Fc Tail region, while the Fc receptor binding region was hardly targeted. A restricted reactivity against the IgG-Fc Tail region was associated with less positivity for anti-citrullinated protein antibodies (ACPAs) and less arthritis development in arthralgia, whereas combined reactivity toward IgG-Fc Tail and Elbow regions was associated with more arthritis development. Reactivity toward the IgG-Fc Tail region was observed far more frequently in RA than in primary SS. CONCLUSION: Bioengineered IgG targets enable serologic characterization of RF reactivity patterns, and use of this approach appears to reveal patterns associated with ACPA detection and arthritis development in patients with arthralgia. These patterns are able to distinguish RA patients from primary SS patients. This new methodology improves the clinical value of RFs and our understanding of their pathophysiologic processes.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Falkenburg WJJ, Oskam N, Koers J, et al. Identification of Clinically and Pathophysiologically Relevant Rheumatoid Factor Epitopes by Engineered IgG Targets. Arthritis Rheumatol. 2020. PMID: 32648642. doi:10.1002/art.41430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。